Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guèrin Therapy

OBJECTIVE: Bacillus Calmette-Guèrin (BCG) intravesical therapy is currently established using a low dose because of the high incidence of side-effects. Moreover, shortening the dwell time of BCG is conducted in some facilities owing to the complications associated with a long dwell time after inject...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Asian Pac J Cancer Prev
Autori principali: Nagai, Takashi, Okamura, Takehiko, Tanaka, Yutaro, Moritoki, Yoshinobu, Kobayashi, Daichi, Kobayashi, Takahiro, Akita, Hidetoshi, Yasui, Takahiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: West Asia Organization for Cancer Prevention 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6857891/
https://ncbi.nlm.nih.gov/pubmed/31127897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.5.1389
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi